PHARMACIST'S COMMENTS
The American College of Physicians-American Society of Internal Medicine (ACP-ASIM) recently published a position paper that explores the increased scope of practice of US pharmacists. 1 The group has taken several positions that you should be aware of.
Position 1: ACP-ASIM supports
research into the effects of pharmacy automation and the move to the PharmD degree on pharmacy practice. Position 2: To improve patient safety and reduce medical errors, ACP-ASIM supports physiciandirected pharmacist-physician collaborative practice agreements limited to pharmacist involvement in patient education and hospital rounds.
• Expanded roles for pharmacists should not be solely based on cost savings. • The responsible physician and pharmacist should be compensated for their time spent on collaborative services. • The physician should solely determine if a relationship will be formed with the pharmacist. • The physician should solely and individually refer a patient to a pharmacist. • Only the physician shall and must diagnose the patient's condition prior to any referral. Position 3: ACP-ASIM opposes independent pharmacist prescriptive privileges and initiation of drug therapy. Position 4: ACP-ASIM supports the use of the pharmacist as an immunization information source, host of immunization sites, and an immunizer, as appropriate and allowed by state law. ACP-ASIM will work with pharmacy organizations to increase immunization awareness. Position 5: ACP-ASIM reiterates its support of its 1990 therapeutic substitution position. ACP-ASIM resolves to work with pharmacists in designing therapeutic substitution policies that ensure the highest level of patient care and safety.
The paper outlines the training (including specialized training) that has accompanied the evolution of our profession in various practice settings. The paper discusses the successes of the profession in several areas, including pharmacist interventions, drug information services, disease management, CPR participation, medication histories, and disease-specific demonstration projects. I was impressed by this recognition of the value of the pharmacy profession and was encouraged by its collaborative tone. However, the successes outlined represent, for the most part, the minimal standard of practice in the hospital environment. What then is the reason for this position paper?
I suspect that if we review Position 3, we will find the answer. The theme of the paper is that physicians are qualified to diagnose and pharmacists' expertise lies with pharmaceuticals.
Perhaps the authors should have taken a less myopic view of the pharmacist's level of diagnostic ability in controlled situations. The paper does not intend to take an adversarial position and recognizes the need for collaboration; however a tempered approach could take advantage of the skills of each profession while increasing the quality of care to the patient at a reduced cost. We must focus on the goal: to provide the highest quality of service at the lowest cost to the ultimate consumer-the patient.
-Dennis J. Cada, PharmD, FASCP, FASHP Editor-in-Chief, Hospital Pharmacy
PHYSICIAN'S COMMENTS
The ACP-ASIM's position paper, while collaborative in tone, appears to perpetuate the differences between the pharmacy and medical communities. Most evident, however, is that little has changed. In fact, it is unclear why the organization expended resources on a position paper that defines pharmacy practice as it has been defined for 20 years. The only position of note is the persistent opposition to patient self-referral to pharmacists.
At a time when health care costs are rising by as much as 30% and the economy is teetering, both government and private sector enterprises are reluctant to spend more. The likelihood of Medicare providing additional dollars for pharmacists is small-they would rather migrate from high-cost physician compensation to lower-cost pharmacist compensation. The equa-Editorial tion is simple: If the same service can be provided for less, then that's how it will be (and should be). During the past 25 years, the quality of pharmacists' training has risen to a level of which we should be proud, and which physicians should trust. The level of pharmacists' expertise should be obvious to physicians who work with Pharmacy and Therapeutics committees. However, physicians who work only in offices and have no interaction with phamacists other than through telephone prescriptions, may not be aware of the resource represented by the profession. This is a physician education issue, not a pharmacist education issue.
Pharmacists are likely to be frustrated witnesses of medication misadventures, errors, and misinterpretations. It would be easy for the medical profession to retort, "But they are not treating the patient." While this is true, the physician record is not very good. Recent data, in part spearheaded by The Institute for Safe Medication Practices, reveals that physicians are not demonstrating exemplary training or behavior. The number of medication-related injuries or deaths is staggering. The economic costs associated with these errors are enormous. Physicians are not in a good position to reject help.
As in all professions, there are exceptional as well as unfavorable examples. The position paper supports physician referral for pharmacist consultation. If you trust your pharmacist, then refer: If you do not, then don't. The important question, and from which the ACP-ASIM deviates from the pharmacy profession, is whether patients should be permitted to self-refer. This observer believes that they should. It appears that physician capacity is limited. The growth in population has not been met by a concomitant increase in physicians. Diminishing compensation coupled with quality-of-life issues forces physicians to see more patients in less time. If ever there were an environment rich in the potential for medication errors, this is it. At the same time, we have a willing profession to whom we can off-load some of the work. As the position paper states, there are numerous research studies illustrating the value of dedicated clinical pharmacist intervention. It is a small step, not a giant leap, to extend this concept to patient self-referral.
Which represents an improvement in the quality of care: The busy physician prescribing antibiotics over the telephone for an upper respiratory infection, or a pharmacist speaking with and observing a patient with the same condition? A telephone prescription for an NSAID vs an observer determining the appropriateness of the drug according to the patient's pain? Pharmacists are not trained in diagnostics. However, many prescriptions are made via the telephone, after talking little more than a brief history. Yes, the history is 90% of the diagnosis, but with the appropriate caveat to follow-up quickly with a physician, the pharmacist and the patient can stay out of trouble. There are limits to what should be allowed, but much of the "clutter" in the busy physician's office could be handled by well-trained phar-macists. Furthermore, patient satisfaction will undoubtedly improve.
The position paper is consistent with a conservative approach. There has been nothing conservative about the explosion in health care innovation and costs during the past 25 years. It is time that we reexamine alternatives that will ease the patient and financial burden. As the hospital lengths-of-stay for myocardial infarction, CABG procedures, pneumonia, and hip replacements have shown, old beliefs die protracted, unpleasant deaths. Let us take a more compassionate approach to this issue.
-James Selevan, MD Physician WebLink/ Monarch HealthCare
